Common germline polymorphisms and somatic cancer mutations exhibit non-random positional overlap across the human genome
Authors:
- Thais Silva TavaresTTThais Silva Tavares
- Renan Pedra de SouzaRSRenan Pedra de Souza
- Thiago Peixoto LealTLThiago Peixoto Leal
- Maycon Douglas de OliveiraMOMaycon Douglas de Oliveira
- Carolina Silva de CarvalhoCCCarolina Silva de Carvalho
- Luigi MarchionniLMLuigi Marchionni
- Mateus Henrique GouveiaMGMateus Henrique Gouveia
- Francisco Pereira LoboFLFrancisco Pereira Lobo
Preprint
Abstract
Germline and somatic mutations have traditionally been studied independently because they arise in distinct biological contexts and are shaped by different selective pressures. Despite these differences, both originate from the same molecular processes of DNA damage, replication error, and DNA repair. Yet this separation has limited the opportunity of investigation of genomic loci recurrently mutated across both mutational landscapes. Identifying such mutational co-occurrences may provide unique insights into the principles governing recurrent mutation. Here, we show that common germline polymorphisms and cancer-associated somatic SNVs recur at identical genomic positions across the human genome, sharing the same nucleotide substitutions more frequently than expected by chance. This recurrence persists within coding regions, is only minimally explained by the canonical hotspot contexts evaluated here (CpG islands and microsatellites), and is associated with a mutational signature profile enriched for the ubiquitous clock-like SBS5 signature together with DNA repair-associated signatures. Importantly, this overlap pattern is not shared across other germline variation: rare (AF<1%) and clinically classified variants exhibit significantly less overlap than expected. Together, these findings support the existence of intrinsically vulnerable genomic loci and provide a framework for investigating the mechanisms underlying recurrent mutation.Keywords
Funding Information
- National Human Genome Research Institute (R00HG012211)
- Chan Zuckerberg Initiative Accelerate Precision Health Program (CZIF2002-007045)
This publication has 52 references indexed in Scilit:
- DNA damage repair and cancer immunotherapyGenome Instability & Disease, 2023
- Unified views on variant impact across many diseasesTrends in Genetics, 2023
- High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 triosCell, 2022
- Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancerThe Breast, 2022
- Hotspots of Human MutationTrends in Genetics, 2021
- Cystic fibrosisThe Lancet, 2021
- Structure and contingency determine mutational hotspots for flower color evolutionEvolution Letters, 2020
- The PI3K Pathway in Human DiseaseCell, 2017
- Data Analysis2016
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin SignalingCell, 2009